EE201 Cost-Effectiveness of Romiplostim for the Treatment of Patients with Early Immune Thrombocytopenia in the Czech Republic
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.450
https://www.valueinhealthjournal.com/article/S1098-3015(22)00651-9/fulltext
Title :
EE201 Cost-Effectiveness of Romiplostim for the Treatment of Patients with Early Immune Thrombocytopenia in the Czech Republic
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00651-9&doi=10.1016/j.jval.2022.04.450
First page :
Section Title :
Open access? :
No
Section Order :
10392